US 12031132
Systems and methods for the treatment of hemoglobinopathies
granted A61KA61K9/0009
Quick answer
US patent 12031132 (Systems and methods for the treatment of hemoglobinopathies) held by Editas Medicine, Inc. expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Editas Medicine, Inc.
- Grant date
- Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K9/0009